Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Waters Corp. (WAT) PT Lowered to $322 at TD Cowen
-
Waters Corp. (WAT) PT Lowered to $333 at TD Cowen
-
TD Cowen on Waters Corp. (WAT): 'Impressive Showcase of Strategy, Execution, Growth & Margins'
-
TD Cowen: 'Assessing Impact of US Ban on China Exports for LCMS & Flow Cyt Instruments'
-
Waters Corp. (WAT) PT Raised to $410 at TD Cowen
-
Waters Corp. (WAT) PT Raised to $363 at TD Cowen
-
Waters Corp. (WAT) PT Raised to $358 at TD Cowen
-
Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference
-
Waters Corporation Presentation at the Cowen 43rd Annual Health Care Conference to be Webcast Live
-
Waters Corp. (WAT) PT Raised to $358 at Cowen
-
Waters Corporation Presentation at the Cowen 42nd Annual Health Care Conference
-
Waters Corp. (WAT) PT Raised to $375 at Cowen, Following Earnings
-
Waters Corp. (WAT) PT Raised to $360 at Cowen
-
Waters Corporation Presentation at the 41st Annual Cowen Healthcare Conference to Be Audio Webcast Live
-
Waters Corp. (WAT) PT Raised to $275 at Cowen
-
Waters Corp. (WAT) PT Raised to $215 at Cowen
-
Waters Corp. (WAT) PT Raised to $205 at Cowen, Following Earnings
-
Seven Life Science Cos Have 15% or More China Revenue Exposure - Cowen
-
Waters Corp. (WAT) PT Lowered to $210 at Cowen
-
Waters Corp. (WAT) PT Lowered to $215 at Cowen
-
Waters Corporation Presentation at the Cowen and Company 38th Annual Health Care Conference to Be Webcast Live
-
Waters Corp. (WAT) PT Raised to $220 at Cowen
-
Waters Corp. (WAT) PT Raised to $175 at Cowen on Strong 1Q Results; 'Pharma & Industrial Drive Revenue Beat, Asia & Europe Strong'
-
Waters Corp. (WAT) PT Raised to $175 at Cowen
-
Legal Pot Business Could Get a Big Jolt on Path to $50B Industry
-
Cowen Downgrades Waters Corp. (WAT) to Neutral
-
Waters Corp. (WAT) Shares Upgraded at Cowen Amid Q2 Miss and Sell-Off
-
Notable Analyst Rating Changes 12/12: PCG, URBN, EIX Upgraded; WAT, F, DRYS, CAT Downgraded
-
Cowen & Co Downgrades Waters (WAT) to Neutral

